Dr. Peter Attia
speaker
5,258 appearances
36 recordings
6 series
first heard Jan 2024
last heard Jun 2025
Dr. Peter Attia’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
That's interesting. So you can't study it. I would assume you couldn't study it with federal dollars because of the federal DEA restriction. I would have assumed because it's legal in California, if you were using non-federal dollars, you could study it in a state like California.
I see. Because it's Schedule 1, the laboratory. It's actually more demanding than how you would study cocaine.
If for no other reason to study it with less friction. Which you said. Perfect. Okay, there's a condition you've already alluded to today that I am sure everyone has heard of, and yet if you asked most people to define it, they wouldn't be able to define it. And so we're going to start with what it is, why someone might have it, what is the prevalence, are there false positives?
I'm talking about none other than fibromyalgia.
What's the prevalence according to the current definition?
But by the way, this is a boy-only thing. I can't imagine girls did this. But yes, of course, this is what little boys do.
Is there a high overlap with depression, anxiety, and fibromyalgia? And if so, which is the arrow of causality?
So what is the management for these patients? Is this a curable syndrome or is it a syndrome that is meant to be managed like HIV?
That's caused by what?
Silly question. Why not five? Like 4.5 has a lot of specificity to it. Was there some reason why it came in at such a dose?
70 kilo person.
What are the other areas where LDN is just captivating the world?
Thalamic pain.
He's tried everything. Let's try low-dose naltrexone. Why does he come to a pain doc? Because he's got terrible pain. Okay, so he wasn't coming to you for the speech issue.
Somehow, if that model makes sense, which it at least teleologically does, something about that inflammatory zone in the middle between what was clearly gone and not is poisoning the part that's still okay. What is the downside of this? Meaning, what would one need to be mindful of in trying an approach like this? The beauty of this
Here's a silly question. Yeah. What's the scenario in which inflammation of the glia is a good thing?
I guess where I'm going with this is we think that at least a subset of people with neurodegenerative diseases, and you mentioned multiple sclerosis, but we think this is true in at least some cases of Alzheimer's disease, that neuroinflammation is a part of the pathology.
So would there be any efficacy to a trial there in either an individual with MCI, mild cognitive impairment, or as crazy as this sounds, is there a reason to consider it prophylactically in high-risk individuals? With the caveat that, hey, by the way, if you happen to get an infection, this would be a good time to stop it and ride it out and get better.
At 10x the dose. How long are they typically on that drug? Lifetime. So meaning for a subset of individuals, just putting them on the party dose of 50 milligrams of naltrexone keeps them free of alcohol and opioids for life because it so blunts the pleasure center.
You have to want to be off.
Showing 1141–1160 of 5,258 · page 58 of 263
← Previous
Next →